CausalSentinel

Protein Dossier — GZMB (Granzyme B)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: M54 Dorsalgia 0.109 0.03 2.70e-04 Wald ratio 1 cis NA
Lung adenocarcinoma -0.132 0.0441 0.00284 Wald ratio 1 cis NA
Neo-agreeableness -0.307 0.106 0.00388 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine -0.0107 0.00413 0.00956 Wald ratio 1 cis NA
Forearm bone mineral density 0.0705 0.0273 0.00994 Wald ratio 1 cis NA
Diagnoses - main ICD10: N40 Hyperplasia of prostate -0.126 0.051 0.0137 Wald ratio 1 cis NA
Lung cancer -0.0698 0.0301 0.0203 Wald ratio 1 cis NA
Cough on most days -0.0538 0.0233 0.0211 Wald ratio 1 cis NA
Alcohol intake frequency -0.0131 0.00637 0.0396 Wald ratio 1 cis NA
Birth weight -0.0132 0.00643 0.0407 Wald ratio 1 cis NA
Mean cell haemoglobin 0.0371 0.0185 0.0455 Wald ratio 1 cis NA
Potassium in urine -0.00867 0.00438 0.0475 Wald ratio 1 cis NA
…and 87 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4133_54_2 Granzyme B Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

16 association rows across 11 traits (16 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating GZMB levels (id: OID00743_OID20604) 2e-571 rs8192917 1 GCST90860084 no MR -> candidate analysis
Circulating GZMB levels (id: OID00840_OID20604) 3e-544 rs8192917 1 GCST90860165 no MR -> candidate analysis
GZMA/GZMB protein level ratio 3e-489 rs8192917 1 GCST90315007 no MR -> candidate analysis
Granzyme B levels (GZMB.4133.54.2) 6e-352 rs8192917 2 GCST90241324 no MR -> candidate analysis
Serum levels of protein GZMB 5e-131 rs8192917 1 GCST90087736 no MR -> candidate analysis
Blood protein levels 3e-83 rs11539752 2 GCST006585 no MR -> candidate analysis
GZMB protein levels 1e-39 rs59268439 3 GCST90469424 no MR -> candidate analysis
Granzyme B (analyte X14041.13) levels 1e-22 rs8192917 1 GCST90422424 no MR -> candidate analysis
Vitiligo 9e-16 rs8192917 2 GCST004785 no MR -> candidate analysis
Hairy/enhancer-of-split related with YRPW motif protein 1 pr 1e-9 rs8192917 1 GCST90437219 no MR -> candidate analysis
Nuclear receptor coactivator 7 protein levels (SomaScan ID:4 3e-8 rs2236338 1 GCST90443089 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 961 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
vitiligo 0.55 common-variant locus no MR -> candidate analysis
respiratory failure 0.448 common-variant locus no MR -> candidate analysis
bone remodeling disease 0.353 common-variant locus no MR -> candidate analysis
respiratory tract neoplasm 0.314 common-variant locus no MR -> candidate analysis
alcohol drinking 0.306 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.158 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 6 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Granzyme B)
gnomAD constraint pLI=1e-10, LOEUF=1.54 — LoF-tolerant
GWAS Catalog 35 unique SNPs / 70 rows
ClinVar 78 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance